VC-backed biopharma company Mineralys Therapeutics raises $192m for IPO

The stock began trading February 10, 2023 on the NASDAQ under the ticker symbol "MLYS."

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this